Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03835780
What this trial is testing

The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study

Who this might be right for
Venous ThrombosesVenous ThromboembolismDeep Vein Thrombosis+6 more
Momentum Data 266,890
Large-scale testing (Phase 3)Active Not RecruitingNCT04908189
What this trial is testing

Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Who this might be right for
Psoriatic Arthritis
Bristol-Myers Squibb 729
Not applicableStudy completedNCT00407979
What this trial is testing

Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis

Who this might be right for
Atopic DermatitisPsoriasis
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableEnded earlyNCT04995783
What this trial is testing

Predicting Medication Response for Autoimmune Disease

Who this might be right for
Ulcerative ColitisCrohn's DiseasePsoriasis+1 more
Coral Genomics, Inc. 200
Post-approval studies (Phase 4)UnknownNCT01223976
What this trial is testing

Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis

Who this might be right for
TuberculosisPsoriasis
Tel-Aviv Sourasky Medical Center 150
Testing effectiveness (Phase 2)Study completedNCT01208090
What this trial is testing

ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Actelion 326
Large-scale testing (Phase 3)Study completedNCT02474082
What this trial is testing

Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 202
Early research (Phase 1)Study completedNCT02097173
What this trial is testing

Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Who this might be right for
Psoriasis
medac GmbH 35
Not applicableStudy completedNCT03925441
What this trial is testing

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

Who this might be right for
Psoriasis
AbbVie 2
Not applicableStudy completedNCT03378336
What this trial is testing

Psoriatic Arthritis Research Collaborative: Biologic Sub-Study

Who this might be right for
Psoriatic Arthritis
University of Pennsylvania 171
Testing effectiveness (Phase 2)Study completedNCT05593432
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Who this might be right for
Cutaneous Lichen Planus
Incyte Corporation 64
Not applicableStudy completedNCT02274363
What this trial is testing

Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis

Who this might be right for
PsoriasisPlaque
Janssen Pharmaceutica 1,131
Not applicableNot Yet RecruitingNCT07597616
What this trial is testing

Periodontal Status in Patients With Oral Lichen Planus

Who this might be right for
Oral Lichen PlanusPeriodontitis
Catholic University of the Sacred Heart 176
Not applicableUnknownNCT05225493
What this trial is testing

HIV Indicator Diseases in Hospital and Primary Care

Who this might be right for
HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more
Erasmus Medical Center 1,500
Large-scale testing (Phase 3)Study completedNCT00111449
What this trial is testing

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Who this might be right for
Psoriasis
Amgen 600
Large-scale testing (Phase 3)Study completedNCT06049810
What this trial is testing

IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

Who this might be right for
Psoriasis
Innovent Biologics (Suzhou) Co. Ltd. 566
Post-approval studies (Phase 4)Study completedNCT00493324
What this trial is testing

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 43
Large-scale testing (Phase 3)Study completedNCT01782937
What this trial is testing

An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT01008995
What this trial is testing

The Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 322
Testing effectiveness (Phase 2)Study completedNCT01722812
What this trial is testing

Cromoglicate in Psoriasis

Who this might be right for
Psoriasis
LEO Pharma 30
Next Page